Propanc Biopharma, Inc. Common Stock (PPCB) — Working Capital to Net Assets Ratio
Propanc Biopharma, Inc. Common Stock (PPCB) has a Working Capital to Net Assets ratio of 39.1% as of December 2025. Working capital of $4.08 Million (current assets of $7.71 Million minus current liabilities of $3.62 Million) is measured against net assets of $10.45 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Propanc Biopharma, Inc. Common Stock to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Propanc Biopharma, Inc. Common Stock Working Capital to Net Assets (2010–2025)
This chart shows how Propanc Biopharma, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of December 2025, the ratio stands at 39.1%, reflecting working capital of $4.08 Million against net assets of $10.45 Million USD. Check Propanc Biopharma, Inc. Common Stock tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Propanc Biopharma, Inc. Common Stock (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Propanc Biopharma, Inc. Common Stock from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Propanc Biopharma, Inc. Common Stock (PPCB) total market value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 20.0% | $2.77 Million | $13.91 Million | $8.35 Million | $5.58 Million | ▼ -79.7 pp |
| 2024 | 99.7% | $-3.77 Million | $-3.78 Million | $25.44K | $3.79 Million | ▼ -1.0 pp |
| 2023 | 100.7% | $-3.14 Million | $-3.12 Million | $19.04K | $3.16 Million | ▼ -0.1 pp |
| 2022 | 100.8% | $-3.05 Million | $-3.02 Million | $15.03K | $3.06 Million | ▲ +0.6 pp |
| 2021 | 100.2% | $-3.07 Million | $-3.07 Million | $6.60K | $3.08 Million | ▼ -0.6 pp |
| 2020 | 100.8% | $-3.67 Million | $-3.64 Million | $69.02K | $3.74 Million | ▲ +0.6 pp |
| 2019 | 100.2% | $-4.31 Million | $-4.30 Million | $91.13K | $4.40 Million | ▲ +0.1 pp |
| 2018 | 100.2% | $-6.76 Million | $-6.75 Million | $60.89K | $6.82 Million | ▼ -0.1 pp |
| 2017 | 100.2% | $-5.45 Million | $-5.44 Million | $81.98K | $5.54 Million | ▼ -0.4 pp |
| 2016 | 100.6% | $-2.58 Million | $-2.57 Million | $362.77K | $2.94 Million | ▲ +0.5 pp |
| 2015 | 100.2% | $-3.06 Million | $-3.05 Million | $621.89K | $3.68 Million | ▲ +0.2 pp |
| 2014 | 100.0% | $-1.41 Million | $-1.41 Million | $113.75K | $1.52 Million | ▼ -0.1 pp |
| 2013 | 100.1% | $-793.01K | $-792.48K | $1.21K | $794.22K | ▼ -0.8 pp |
| 2012 | 100.9% | $-542.54K | $-537.92K | $41.65K | $584.19K | ▲ +1.2 pp |
| 2011 | 99.7% | $10.47 Million | $10.51 Million | $10.78 Million | $306.85K | ▼ -2.4 pp |
| 2010 | 102.1% | $-190.82K | $-186.90K | $39.95K | $230.76K | — |